Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VEEV vs GSK✓SelectedUSD · GSKVEEV vs GSK performance historyLatest closeAs of-0.75%11/16
Stock and ETF performance explorer

VEEV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+705.4%
GSK return
+92.0%
Excess return
+613.4%
Maximum drawdown
-61.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.7%-0.7%
7D-2.3%-1.3%-1.0%-1.8%
30D-3.6%+2.7%-6.3%-4.7%
3M+22.8%+2.7%+20.1%+20.9%
6M+88.4%+3.3%+85.1%+84.5%
YTD+34.1%+6.5%+27.6%+27.8%
1Y+2.0%+10.7%-8.6%-4.5%
3Y+70.7%+64.4%+6.4%+29.0%
5Y-6.4%+46.7%-53.1%-26.8%
10Y+634.6%+109.4%+525.3%+354.0%
All+705.4%+92.0%+613.4%+382.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling